0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$44.00
This product is available by prescription only
This product does not require a prescription
Out Of Stock
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
Ipamorelin targets GH secretion with high receptor selectivity while producing minimal effects on prolactin, cortisol, or feeding behavior pathways in experimental models. This selectivity allows research teams to investigate GH-related mechanisms without introducing hormonal confounds, enabling clean, reproducible endpoint data across preclinical study designs.
Unlike other GHRPs, Ipamorelin produces negligible activation of appetite signaling pathways in experimental models. This property is advantageous for study designs where feeding behavior or energy intake parameters could introduce confounding variables, enabling controlled investigation of GH-specific mechanisms in isolation.
Produced in certified USA GMP facilities, each vial of Ipamorelin 5mg includes a full Certificate of Analysis (COA) verifying peptide purity and sequence integrity. Rigorous quality control protocols ensure reproducibility and reliability across all laboratory applications.
Ipamorelin 5mg is designed for research teams investigating selective GH secretagogue mechanisms, isolated GH pulsatility, and ghrelin receptor agonism in experimental models. It is particularly suited for laboratories studying GH pathway modulation where confounding variables such as cortisol elevation, prolactin changes, or appetite signal interference must be minimized to maintain experimental integrity. Research teams examining GH-mediated downstream signaling, metabolic pathway modulation, or multi-component hormonal cascade dynamics benefit from Ipamorelin’s well-characterized selectivity profile. All Novera Ipamorelin is manufactured in USA GMP-certified facilities to ensure pharmaceutical-grade quality and consistent experimental outcomes.
Ipamorelin enables precise investigation of GH secretion dynamics without confounding off-target hormonal effects. Preclinical study designs employing Ipamorelin can assess isolated GH pulse characteristics, ghrelin receptor-mediated signaling, and downstream GH pathway modulation with minimal interference from parallel hormonal systems.
In experimental models, Ipamorelin supports investigation of GH-mediated metabolic pathway modulation. Research designs may examine GH-specific effects on lipid metabolism, glucose dynamics, and related metabolic endpoints while maintaining tight experimental control over hormonal variables.
Ipamorelin is frequently employed alongside GHRH peptides such as CJC-1295 in experimental protocols examining synergistic or additive GH secretion effects. These multi-component study designs allow investigation of combined secretagogue mechanisms and GH cascade amplification within preclinical models.
State-of-the-art synthesis achieves nearly 99% purity, providing a highly reliable GHRP for laboratory investigations focused on selective GH pathway analysis and reproducible experimental outcomes.
Store lyophilized Ipamorelin at 2–8°C in a cool, dark environment prior to reconstitution. Protect from light at all times to preserve peptide structural integrity. This product does not require cold chain shipping under standard laboratory receiving conditions.
Reconstitute with sterile bacteriostatic water under strict aseptic technique in accordance with institutional laboratory safety and biosafety protocols. Following reconstitution, the solution must be refrigerated immediately and used within the timeframe specified in accompanying experimental documentation. Detailed reconstitution instructions are provided with each vial.
Lyophilized material stored at recommended temperatures retains integrity for extended periods. Reconstituted Ipamorelin should be maintained under sterile refrigerated conditions throughout the study duration to preserve peptide activity and ensure reproducible experimental results.
Preclinical protocols examining GH secretion and downstream signaling endpoints are typically designed for 8–16 week observation periods. Initial measurable GH responses in experimental models may be observed within 2–4 weeks of protocol initiation, with more comprehensive endpoint data generally emerging by weeks 8–12. Laboratory monitoring should systematically capture GH secretion markers, relevant metabolic parameters, and additional endpoints defined by the experimental objectives to ensure data reproducibility.
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
Research-grade selective synthetic pentapeptide formulated for experimental peptide interaction research in controlled laboratory settings.
Research-grade dual GIP/GLP-1 peptide by NOVERA, USA-made, 99% purity, for advanced metabolic studies.
Research-grade dual-peptide formulation combining two synthetic peptides for streamlined laboratory peptide research protocols.
Research-grade synthetic nonapeptide supplied in 5mg format for controlled in vitro laboratory investigation.
Research-grade synthetic dual-agonist peptide formulated in higher-quantity 15mg format for extended dual-receptor pathway studies and institutional peptide research in controlled laboratory environments.
